EVOLV TECHNOLOGIES HOLDINGS (EVLV)

US30049H1023 - Common Stock

3.66  -0.31 (-7.81%)

After market: 3.72 +0.06 (+1.64%)

Fundamental Rating

3

Taking everything into account, EVLV scores 3 out of 10 in our fundamental rating. EVLV was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. EVLV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EVLV is valued quite expensively, but it does show have an excellent growth rating.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EVLV has reported negative net income.
In the past year EVLV has reported a negative cash flow from operations.
EVLV had negative earnings in each of the past 5 years.
EVLV had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of EVLV (-7.10%) is worse than 62.81% of its industry peers.
EVLV has a Return On Equity of -12.46%. This is in the lower half of the industry: EVLV underperforms 61.98% of its industry peers.
Industry RankSector Rank
ROA -7.1%
ROE -12.46%
ROIC N/A
ROA(3y)-21.13%
ROA(5y)-54.56%
ROE(3y)-38.14%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EVLV has a better Gross Margin (53.68%) than 92.56% of its industry peers.
In the last couple of years the Gross Margin of EVLV has grown nicely.
EVLV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.03%
GM growth 5YN/A

More info and screens

5

2. Health

2.1 Basic Checks

EVLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
EVLV has more shares outstanding than it did 1 year ago.
There is no outstanding debt for EVLV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

EVLV has an Altman-Z score of 1.20. This is a bad value and indicates that EVLV is not financially healthy and even has some risk of bankruptcy.
EVLV's Altman-Z score of 1.20 is on the low side compared to the rest of the industry. EVLV is outperformed by 73.55% of its industry peers.
EVLV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC10.29%

2.3 Liquidity

A Current Ratio of 1.74 indicates that EVLV should not have too much problems paying its short term obligations.
The Current ratio of EVLV (1.74) is worse than 69.42% of its industry peers.
A Quick Ratio of 1.50 indicates that EVLV should not have too much problems paying its short term obligations.
EVLV's Quick ratio of 1.50 is in line compared to the rest of the industry. EVLV outperforms 40.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.5

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.17% over the past year.
Looking at the last year, EVLV shows a quite strong growth in Revenue. The Revenue has grown by 17.66% in the last year.
Measured over the past years, EVLV shows a very strong growth in Revenue. The Revenue has been growing by 156.06% on average per year.
EPS 1Y (TTM)36.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)17.66%
Revenue growth 3Y156.06%
Revenue growth 5YN/A
Sales Q2Q%28.83%

3.2 Future

EVLV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.13% yearly.
Based on estimates for the next years, EVLV will show a very strong growth in Revenue. The Revenue will grow by 29.06% on average per year.
EPS Next Y27.41%
EPS Next 2Y28.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.25%
Revenue Next 2Y30.83%
Revenue Next 3Y49.35%
Revenue Next 5Y29.06%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVLV. In the last year negative earnings were reported.
Also next year EVLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EVLV's earnings are expected to grow with 28.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.13%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVLV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVOLV TECHNOLOGIES HOLDINGS

NASDAQ:EVLV (1/6/2025, 4:30:02 PM)

After market: 3.72 +0.06 (+1.64%)

3.66

-0.31 (-7.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-08 2024-11-08/amc
Earnings (Next)N/A N/A
Inst Owners54.08%
Inst Owner Change0%
Ins Owners5.23%
Ins Owner Change0.74%
Market Cap576.63M
Analysts78
Price Target4.93 (34.7%)
Short Float %11.35%
Short Ratio5.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.28%
Min EPS beat(2)-32.35%
Max EPS beat(2)19.78%
EPS beat(4)3
Avg EPS beat(4)2.7%
Min EPS beat(4)-32.35%
Max EPS beat(4)19.78%
EPS beat(8)7
Avg EPS beat(8)7.24%
EPS beat(12)10
Avg EPS beat(12)36.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-7.63%
Max Revenue beat(2)5.03%
Revenue beat(4)3
Avg Revenue beat(4)3.19%
Min Revenue beat(4)-7.63%
Max Revenue beat(4)10.67%
Revenue beat(8)7
Avg Revenue beat(8)30.99%
Revenue beat(12)11
Avg Revenue beat(12)35.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.69%
PT rev (3m)-4.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.46
P/FCF N/A
P/OCF N/A
P/B 3.77
P/tB 3.77
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.57
BVpS0.97
TBVpS0.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.1%
ROE -12.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.68%
FCFM N/A
ROA(3y)-21.13%
ROA(5y)-54.56%
ROE(3y)-38.14%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.03%
GM growth 5YN/A
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 429.51%
Cap/Sales 63.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.5
Altman-Z 1.2
F-Score4
WACC10.29%
ROIC/WACCN/A
Cap/Depr(3y)405.5%
Cap/Depr(5y)393.89%
Cap/Sales(3y)46.91%
Cap/Sales(5y)58.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y27.41%
EPS Next 2Y28.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.66%
Revenue growth 3Y156.06%
Revenue growth 5YN/A
Sales Q2Q%28.83%
Revenue Next Year31.25%
Revenue Next 2Y30.83%
Revenue Next 3Y49.35%
Revenue Next 5Y29.06%
EBIT growth 1Y13.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.06%
EBIT Next 3Y45.6%
EBIT Next 5Y28.17%
FCF growth 1Y13.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.2%
OCF growth 3YN/A
OCF growth 5YN/A